Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401708-17-000074
Filing Date
2017-09-05
Accepted
2017-09-05 17:27:39
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150464684616298.html 4  
1 FORM 4 wf-form4_150464684616298.xml 4 3851
  Complete submission text file 0001401708-17-000074.txt   5230
Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
JOHNSON JAMES A (Reporting) CIK: 0001225501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35980 | Film No.: 171069647

Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Issuer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)